Systematic Approach to Pharmacovigilance beyond the Limits: The Southern Network on Adverse Reactions (SONAR) Projects

Marcos Cardoso Rios^1,5,7, Evelyne De Andrade Mota¹, Layana Tyara Sandes Fraga¹, Saulo Makerran Loureiro^1,7, Tereza Virgínia Silva Bezerra Nascimento^1,2, Ângelo Roberto Antoniolli¹, Divaldo Pereira De Lyra-Junior¹, Alex Franca^1,2,3, Ramie Leibnitz^1,4, John Restaino¹, Whitney Maxwell¹, LeAnn B Norris^1,5, Zaina P Qureshi^1,2, Linda Martin¹, Bryan L Love¹, Brandon Bookstaver¹, Scott Sutton¹, Raja Fayad², Sony Jacob⁵, Peter Georgantopoulos^1,2,5, Oliver SaOliver Sartorrtor^1,9, Paul RYarnold¹, Dinah Huff1¹⁰, William Hrusheshky¹⁰, Dennis W Raisch RPh^1,6, Richard Ablin^1,8 and Charles L Bennett^1,2,5,7*

¹The Southern Network on Adverse Reaction (SONAR) project, the South Carolina Center of Economic Excellence for Medication Safety, the South Carolina College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA, E-mail: mcrios_farma@yahoo.com.br

²University of South Carolina, Arnold School of Public Health, Columbia, South Carolina, USA, E-mail: mcrios_farma@yahoo.com.br

³University of South Carolina, School of Medicine, Columbia, South Carolina, USA, E-mail: mcrios_farma@yahoo.com.br

⁴Lead Horse Technologies, Inc., Junction City, Kansas, USA, E-mail: mcrios_farma@yahoo.com.br

⁵WJB Dorn VA Medical Center, Columbia, South Carolina, USA, E-mail: mcrios_farma@yahoo.com.br

⁶College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA, E-mail: mcrios_farma@yahoo.com.br

⁷Medical University of South Carolina, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA, E-mail: mcrios_farma@yahoo.com.br

⁸University of Arizona College of Medicine, Phoenix, Arizona, USA, E-mail: mcrios_farma@yahoo.com.br

⁹Tulane University School of Medicine, New Orleans, Louisiana, USA, E-mail: mcrios_farma@yahoo.com.br

¹⁰Oncology Analytics Inc., Plantation, Florida, USA, E-mail: mcrios_farma@yahoo.com.br

^*Corresponding Author: